Ruiz, Analyn A.
HRN: 00-13-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/17/2026
07/23/2026
IV
500mg
Q8
Enterocutaneous Fistula
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes